Scavenging of Alzheimer's amyloid beta-protein by microglia in culture

被引:0
|
作者
Ard, MD
Cole, GM
Wei, J
Mehrle, AP
Fratkin, JD
机构
[1] UNIV MISSISSIPPI,MED CTR,DEPT PATHOL,JACKSON,MS 39216
[2] UNIV CALIF LOS ANGELES,DEPT MED,LOS ANGELES,CA 90024
[3] VET ADM MED CTR,CTR GERIATR RES EDUC & CLIN,SEPULVEDA,CA 91343
关键词
amyloid beta-protein; A beta(1-42); central nervous system phagocytes; microglia;
D O I
10.1002/(SICI)1097-4547(19960115)43:2<190::AID-JNR7>3.0.CO;2-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Deposits of amyloid beta-protein (A beta) form the cores of the pathological plaques which characterize Alzheimer's disease. The mechanism of formation of the deposits is unknown; one possibility is failure of a clearance mechanism that would normally remove the protein from brain parenchyma. This study has investigated the capacity of the central nervous system (CNS) phagocytes, microglia cells, to clear exogenous A beta(1-42) from their environment, Cultured microglia from adult rat CNS have a high capacity to remove A beta from serum-free medium, shown by immunoblotting experiments, A beta from incubation medium was attached to the cell surface and could be identified by immunocytochemistry at the light or electron microscopic (EM) level; by EM, A beta also appeared in phagosome-like intracellular vesicles. Light microscopic immunocytochemistry combined with computer-assisted image analysis showed that cells accumulated A beta within 24 hr, from culture medium containing from 1 to 20 mu g/ml A beta. Microglial accumulation of A beta was substantially reduced in the presence of fetal bovine serum. Addition of the protease inhibitor leupeptin to incubation medium with serum resulted in accumulation of A beta in a membrane-bound intracellular compartment, but not at the cell surface, The increase in intracellular accumulation in the presence of the protease inhibitor indicates a microglial capacity for intracellular degradation of A beta in the absence of inhibition, The change from predominantly cell-surface accumulation in serum-free medium to predominantly intracellular accumulation with serum may be explained by the presence in serum of carrier proteins that complex with A beta and target it to cell surface receptors capable of stimulating endocytosis. Microglia were also cultured on unfixed cryostat sections of human brain tissue containing Alzheimer's plaques. Very little A beta from the tissue was accumulated by the cells, although cultured microglia were found in direct contact with anti-A beta immunopositive plaques. Possibly A beta in tissue sections was complexed with other proteins which either inhibited its uptake by microglia or enhanced its proteolysis, preventing cellular accumulation of immunostainable A beta. The results indicate that cultured microglia effectively remove A beta from tissue culture medium and from the surface of the dish and concentrate monomer and aggregates of A beta either on the cell surface or intracellularly. This process may be modified by proteins present in Alzheimer's brain sections. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:190 / 202
页数:13
相关论文
共 50 条
  • [1] Is amyloid beta-protein glycated in Alzheimer's disease?
    Tabaton, M
    Perry, G
    Smith, M
    Vitek, M
    Angelini, G
    Dapino, D
    Garibaldi, S
    Zaccheo, D
    Odetti, P
    NEUROREPORT, 1997, 8 (04) : 907 - 909
  • [2] Amyloid beta-protein and the genetics of Alzheimer's disease
    Selkoe, DJ
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) : 18295 - 18298
  • [3] Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein
    Cole, GM
    Ard, MD
    MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 50 (04) : 316 - 324
  • [4] Inhibition of amyloid beta-protein formation for the treatment of Alzheimer's disease
    McDonald, IA
    Munoz, B
    Wang, BW
    Li, HZ
    Albrecht, E
    Provow, S
    Farrow, J
    Holtz, G
    Turner, M
    Wagner, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 212 - MEDI
  • [5] Amyloid beta-protein 42, Alzheimer's disease, and Down's syndrome
    不详
    NEUROSCIENTIST, 1996, 2 (04): : 201 - 201
  • [6] THE ROLE OF AMYLOID BETA-PROTEIN IN ALZHEIMER-DISEASE
    REGLAND, B
    GOTTFRIES, CG
    LANCET, 1992, 340 (8817): : 467 - 469
  • [7] ALZHEIMER AMYLOID BETA-PROTEIN PRECURSOR IN SPERM DEVELOPMENT
    SHOJI, M
    KAWARABAYASHI, T
    HARIGAYA, Y
    YAMAGUCHI, H
    HIRAI, S
    KAMIMURA, T
    SUGIYAMA, T
    AMERICAN JOURNAL OF PATHOLOGY, 1990, 137 (05): : 1027 - 1032
  • [8] Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease
    Cai, Zhiyou
    Hussain, M. Delwar
    Yan, Liang-Jun
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2014, 124 (05) : 307 - 321
  • [9] RELEASE OF EXCESS AMYLOID BETA-PROTEIN FROM A MUTANT AMYLOID BETA-PROTEIN PRECURSOR
    CAI, XD
    GOLDE, TE
    YOUNKIN, SG
    SCIENCE, 1993, 259 (5094) : 514 - 516
  • [10] Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells
    Paresce, DM
    Chung, HY
    Maxfield, FR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (46) : 29390 - 29397